“…Opioid-polydrug use during pregnancy is associated with a myriad of adverse outcomes for mothers and infants, such as increased odds of maternal death during hospitalization, placental abruption, preterm labor, Cesarean delivery, transfusion and extended hospital stays > 7 days (Maeda et al, 2014). It is also associated with prematurity, low birthweight, congenital anomalies, greater likelihood of pharmacological treatment of NAS, longer hospital stays, and higher risks for developmental problems (Abdel-Latif et al, 2013). Importantly, the association between mental health and substance use disorders must not be neglected when developing more efficient intervention strategies for the reduction of drug use during pregnancy; mental disorders and substance use disorders do not only have mutually exacerbating effects, but also contribute individually and synergistically to adverse pregnancy outcomes.…”